TREM2 and Alzheimer disease: A hypomorphic variant of TREM2 is associated with elevated risk of late-onset AD in humans while TREM2 loss of function mutations as associated with dementia, and mice deficient in TREM2 develop AD-associated pathologies (88, 89).